Minasian L

ORCID: 0000-0002-0472-4079 · 4 papers in corpus
2019
New strategies in ovarian cancer treatment.
Cancer ·doi:10.1002/cncr.32544

Insights from basic science dissecting carcinogenesis in the fallopian tube and ovary have led to a deeper understanding of the origin, molecular characteristics, and types of ovarian cancers. This logically then has led to the development …

2017
Ovarian Cancer Prevention in High-risk Women.
Clinical Obstetrics and Gynecology ·doi:10.1097/grf.0000000000000318

Ovarian carcinoma is the most lethal malignancy of the female genital tract. Population-based trials in the general population have not demonstrated that screening improves early detection or survival. Therefore, application of prevention s…

2016
The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?
Frontiers in oncology ·doi:10.3389/fonc.2016.00089

Population-level cancer incidence rates are one measure to estimate the cancer burden. The goal is to provide information on trends to measure progress against cancer at the population level and identify emerging patterns signifying increas…

2014
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
Journal of Clinical Oncology ·doi:10.1200/jco.2013.54.1987

PurposeRisk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovarian/tubal and breast cancers among BRCA1/2 mutation carriers. Uncertainties persist regarding potential benefits of RRSO among high-risk noncarriers, optimal surgic…